|
big pharma briefs: Israel, EnClear & ProMIS
BCLI: Hospital Exemption Approved in Israel; First Patient Enrolled in Phase 2 Study in Progressive MS…
Zacks Small Cap Research - BCLI: Hospital Exemption Approved in Israel; First Patient Enrolled in Phase 2 Study in Progressive MS… . . . enClear AstraZeneca vet Jennifer Butler takes charge of Innate Pharma’s US biz; C4 raids NIBR – Endpoints News . . . ProMIS ProMIS Neurosciences Announces Fiscal Year 2�18 Annual Results |
| All times are GMT -5. The time now is 12:16 AM. |
Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.